Fri, Aug 2, 11:35 AM (190 days ago)
Twist Bioscience Corporation filed a Form 8-K on August 2, 2024, to announce its financial results for the quarter ending June 30, 2024. The report, signed by Assistant General Counsel Judy Yan, includes a press release detailing the financial performance. The company is registered under the trading symbol TWST on the Nasdaq Global Select Market. No major corporate events, mergers, acquisitions, leadership changes, or bankruptcy filings were reported. The financial results are furnished under Item 2.02 and are not incorporated by reference into any other filings. This update is primarily for informational purposes and does not impact the company's stock value or financial position directly.